Melatonin for Sleep: What the Trials Actually Show About Dose and Timing

⚠️ Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making any health decisions.

The Honest Starting Point: Melatonin's Effect Is Real but Modest

Melatonin is one of the most widely used sleep supplements, and the trial evidence backs a real, if modest, effect. A meta-analysis published in PLOS ONE pooled 19 randomized controlled trials with 1,683 participants and found melatonin reduced the time it takes to fall asleep by about 7 minutes on average (95% CI: 4.37–9.75 minutes, P<.001), increased total sleep time by about 8 minutes (95% CI: 1.74–14.75 minutes, P=.013), and produced a small but statistically significant improvement in overall sleep quality (standardized mean difference = 0.22, P<.001). The authors also noted the effect didn't fade with continued use -- a real advantage over some sleep medications that lose effectiveness over time. But by the numbers, this is a modest nudge, not a dramatic fix.

The 2024 Finding: Most People May Be Dosing It Wrong

A more recent dose-response meta-analysis in the Journal of Pineal Research, pooling 26 randomized controlled trials and 1,689 observations spanning studies from 1987 to 2020, dug into exactly how dose and timing change the result. It found the sleep-promoting effect keeps increasing with dose up to about 4 mg/day, and that taking melatonin roughly 3 hours before the desired bedtime outperformed the far more common practice of taking 2 mg around 30 minutes before bed. In other words, standard over-the-counter usage -- a low dose taken right before lights-out -- may be missing a meaningful part of the benefit the trials actually measured.

Why Timing Matters More Than People Expect

Melatonin's role in the body is to signal the onset of the biological night, not to sedate on contact. Taken right before bed, it arrives after that signaling window has largely already needed to happen; taken a few hours earlier, it more closely mimics the body's own melatonin rise and gives the circadian system time to respond. This is a mechanistic explanation for why the 2024 analysis found earlier timing outperformed the common last-minute approach -- it isn't a sedative in the way many people assume.

Practical Takeaway

  • Across pooled trials, melatonin's average effect on sleep onset and duration is real but modest -- a matter of minutes, not hours
  • The dose-response evidence suggests up to about 4 mg/day, higher than many over-the-counter products default to (which are often 1-3 mg)
  • Taking it earlier -- roughly 3 hours before the target bedtime rather than right before -- more closely matches how the body's own melatonin signaling works and tracked with a better result in the pooled data
  • Melatonin's benefit didn't fade with continued use in the trials reviewed, unlike some sleep medications, though it remains a modest tool rather than a substitute for addressing an underlying sleep disorder

References & Further Reading

  1. Ferracioli-Oda E, Qawasmi A, Bloch MH. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773.
  2. Cruz-Sanabria F, Bruno S, Crippa A, Frumento P, Scarselli M, Skene DJ, Faraguna U. (2024). Optimizing the time and dose of melatonin as a sleep-promoting drug: a systematic review of randomized controlled trials and dose-response meta-analysis. Journal of Pineal Research, 76(5), e12985.